Found 4 matching trials
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer PHASE2 This is a Phase 2 clinical trial, which tests two investigational drugs: TP...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE1 This phase I clinical trial studies the side effects of vaccine therapy and...
Show More Learn More & Join Trial
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer PHASE2 This randomized phase II trial studies how well multi-epitope folate recept...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Learn More & Join Trial
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer EARLY_PHASE1 This pilot clinical trial studies the safety and immunogenicity of vaccine ...
Show More Learn More & Join Trial